Kim Blickenstaff
Directeur/Membre du Conseil chez OPY ACQUISITION CORP. I
Fortune : 8 M $ au 30/04/2024
Profil
Kim D. Blickenstaff a fondé Alere San Diego, Inc. Actuellement, M. Blickenstaff est président du conseil d'administration de Tandem Diabetes Care, Inc. M. Blickenstaff siège également au conseil d'administration d'Astute Medical, Inc. et de Nuvation Bio Operating Co. M. Blickenstaff a précédemment occupé le poste de président-directeur général d'Alere San Diego, Inc. et de président-directeur général de Biosite, Inc. (Massachusetts), de directeur chez Baxter Healthcare Corp. et de directeur chez Hybritech, Inc. M. Blickenstaff a obtenu un diplôme de premier cycle à l'université Loyola de Chicago et un MBA à la Quinlan School of Business.
Détentions connues dans des sociétés publiques
| Société | Date | Nombre d'actions | Valorisation | Date de valorisation |
|---|---|---|---|---|
| 24/05/2024 | 223 038 ( 0,35% ) | 8 M $ | 30/04/2024 | |
| 15/05/2023 | 0 ( -.--% ) | - $ | 30/04/2024 |
Postes actifs de Kim Blickenstaff
| Sociétés | Poste | Début |
|---|---|---|
| NUVATION BIO INC. | Directeur/Membre du Conseil | 01/08/2019 |
| OPY ACQUISITION CORP. I | Directeur/Membre du Conseil | 01/10/2021 |
Astute Medical, Inc.
 Astute Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Astute Medical, Inc. discovers and develops biomarkers for acute conditions and diseases. It develops protein biomarker-based diagnostics technology for high-risk medical conditions such as cerebrovascular injury, kidney injury, sepsis, abdominal pain, and acute coronary syndromes. The firm’s products include NephroCheck test and Astute140 meter kits. The company was founded by Christopher Richard Hibberd and Paul H. McPherson in 2007 and is headquartered in San Diego, CA. | Directeur/Membre du Conseil | 12/05/2010 |
Nuvation Bio Operating Co., Inc.
 Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | Directeur/Membre du Conseil | - |
Respiratory Motion, Inc.
 Respiratory Motion, Inc. Medical SpecialtiesHealth Technology Respiratory Motion, Inc. develops medical devices. The firm specializes in clinical research, clinical evaluation and testing. Its product ExSpiron 1Xi, measures minute ventilation non-invasively. The company was founded by Jenny E. Freeman, Alexander Panasyuk and Svetlana Panasyuk in March 2010 and is headquartered in Waltham, MA. | Directeur/Membre du Conseil | - |
Anciens postes connus de Kim Blickenstaff
| Sociétés | Poste | Fin |
|---|---|---|
| TANDEM DIABETES CARE, INC. | Directeur Général | 01/03/2019 |
| Medivation, Inc. /Old/ | Directeur/Membre du Conseil | 01/01/2016 |
MediSpectra, Inc.
 MediSpectra, Inc. Miscellaneous Commercial ServicesCommercial Services MediSpectra, Inc. develops and manufactures medical devices. The firm develops proprietary optical detection technology for enhanced accuracy and real time results in the detection of cancer & other human tissue abnormalities. Its technology is based on multimodal optical interrogation of tissues with light. The company was founded in 1995 and is headquartered in Lexington, MA. | Directeur/Membre du Conseil | 26/03/2010 |
Amira Medical, Inc.
 Amira Medical, Inc. Medical SpecialtiesHealth Technology Founded in 1996, Amira Medical develops and markets glucose monitoring products. In particular, it has pioneered proprietary technology to enable users to draw a small blood sample from areas of the body other than the fingertips | Directeur/Membre du Conseil | 19/09/2007 |
| ░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░░░ ░░ ░░░░░░░ | ░░░░░░░░░░ |
Formation de Kim Blickenstaff
| Loyola University of Chicago | Undergraduate Degree |
| Quinlan School of Business | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 3 |
|---|---|
| DEXCOM, INC. | Health Technology |
| TANDEM DIABETES CARE, INC. | Health Technology |
| NUVATION BIO INC. | Health Technology |
| Entreprise privées | 15 |
|---|---|
SenoRx, Inc.
 SenoRx, Inc. Medical SpecialtiesHealth Technology SenoRx, Inc. develops and manufactures invasive devices for the diagnosis and treatment of breast cancer. The company was founded in 1998 and is headquartered in Tempe, AZ. | Health Technology |
Predictive Biosciences, Inc.
 Predictive Biosciences, Inc. Medical/Nursing ServicesHealth Services Predictive Biosciences is a fully-integrated developer of novel molecular diagnostic cancer assays, and a subspecialty, urology-focused provider of anatomic pathology laboratory products and services. The Company pioneered the Clinical Intervention Determining Diagnostic (CIDD) and Multi-Analyte Diagnostic Readout (MADR) approaches to cancer management, leveraging its portfolio of patented biomarkers and clinical algorithms. Based on these approaches, the Company is building a unique portfolio of assays that enable physicians to reliably determine the presence or absence of cancer with very high levels of confidence. Predictive Biosciences' first tests are targeted toward the growing bladder cancer and prostate cancer survivor populations and the large number of individuals undergoing clinical workups for these malignancies. Predictive Biosciences' corporate headquarters and innovation center is located in Lexington, Massachusetts. The Company's commercial division, OncoDiagnostic Laboratory (ODL), is located in Cleveland, Ohio. ODL is a Clinical Laboratory Improvement Act (CLIA)-certified anatomic pathology and molecular diagnostics lab with a national sales force serving urologists, gastroenterologists, dermatologists, gynecologists, and other subspecialty physicians. Founded in 2006, Predictive Biosciences is privately funded by Flybridge Capital Partners, Highland Capital Partners, Kaiser Permanente Ventures and New Enterprise Associates. | Health Services |
MediSpectra, Inc.
MediSpectra, Inc. Miscellaneous Commercial ServicesCommercial Services MediSpectra, Inc. develops and manufactures medical devices. The firm develops proprietary optical detection technology for enhanced accuracy and real time results in the detection of cancer & other human tissue abnormalities. Its technology is based on multimodal optical interrogation of tissues with light. The company was founded in 1995 and is headquartered in Lexington, MA. | Commercial Services |
GeneOhm Sciences, Inc.
 GeneOhm Sciences, Inc. Medical SpecialtiesHealth Technology GeneOhm Sciences, Inc. develops molecular diagnostic products. It offers methicillin-resistant staphylococcus aureus (MRSA) Assay an in vitro diagnostic test for the direct detection of MRSA from a nasal specimen. The company was founded on 2001 and is headquartered in Franklin Lakes, NJ. | Health Technology |
Micro Therapeutics, Inc.
 Micro Therapeutics, Inc. Medical SpecialtiesHealth Technology Micro Therapeutics, Inc. develops, manufactures and markets invasive medical devices for the diagnosis and treatment of vascular diseases. Its products include infusion catheters, ballon catheters, delivery catheters, guide wires, infusion wires, and thrombolytic brushes. The company was founded in 1993 and is headquartered in Irvine, CA | Health Technology |
Amira Medical, Inc.
Amira Medical, Inc. Medical SpecialtiesHealth Technology Founded in 1996, Amira Medical develops and markets glucose monitoring products. In particular, it has pioneered proprietary technology to enable users to draw a small blood sample from areas of the body other than the fingertips | Health Technology |
Hybritech, Inc.
 Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Hybritech, Inc. provides prostate diagnostic testing services. The company is headquartered in San Diego, CA. | Commercial Services |
Baxter Healthcare Corp.
 Baxter Healthcare Corp. Medical SpecialtiesHealth Technology Baxter Healthcare Corp. develops, manufactures, and distributes hospital supplies and medical technologies. It distributes medical treatment options for conditions such as hemophilia, immune disorders, kidney disease, cancer, and trauma. The company was founded on June 21, 1967 and is headquartered in Deerfield, IL. | Health Technology |
Astute Medical, Inc.
Astute Medical, Inc. Electronic Equipment/InstrumentsElectronic Technology Astute Medical, Inc. discovers and develops biomarkers for acute conditions and diseases. It develops protein biomarker-based diagnostics technology for high-risk medical conditions such as cerebrovascular injury, kidney injury, sepsis, abdominal pain, and acute coronary syndromes. The firm’s products include NephroCheck test and Astute140 meter kits. The company was founded by Christopher Richard Hibberd and Paul H. McPherson in 2007 and is headquartered in San Diego, CA. | Electronic Technology |
Alere San Diego, Inc.
 Alere San Diego, Inc. Medical SpecialtiesHealth Technology Alere San Diego, Inc. develops, manufactures, and markets, diagnostic products. The company was founded by Kim D. Blickenstaff and Gunars E. Valkirs on June 28, 1988 and is headquartered in San Diego, CA. | Health Technology |
| Biosite, Inc. (Massachusetts) | |
Nuvation Bio Operating Co., Inc.
Nuvation Bio Operating Co., Inc. Pharmaceuticals: MajorHealth Technology Nuvation Bio Operating Co., Inc. engages in the provision of biotechnology company developing proprietary therapies focuse on oncology. It portfolio includes Seven Novel and Mechanistically Distinct Oncology Programs, Each with Multiple Drug Development Candidates. The company was founded by David Hung in 2018 and is headquartered in New York, NY. | Health Technology |
| Medivation, Inc. /Old/ | Health Technology |
OPY Acquisition Corp. I
 OPY Acquisition Corp. I Financial ConglomeratesFinance OPY Acquisition Corp. I is blank check company, which engages in effecting a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization or similar business combination. The company was founded July 20, 2020 and is headquartered in New York, NY. | Finance |
Respiratory Motion, Inc.
Respiratory Motion, Inc. Medical SpecialtiesHealth Technology Respiratory Motion, Inc. develops medical devices. The firm specializes in clinical research, clinical evaluation and testing. Its product ExSpiron 1Xi, measures minute ventilation non-invasively. The company was founded by Jenny E. Freeman, Alexander Panasyuk and Svetlana Panasyuk in March 2010 and is headquartered in Waltham, MA. | Health Technology |